Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Patent US7790681 - Treatment of cardiac arrhythmias with GLP-1 receptor ligands
BluVial 1mg Injection is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight
Users report feeling fuller for longer periods, which naturally leads to a decrease in calorie consumption without the constant battle with hunger
Patients who want to lose 20 pounds or more are also good candidates for this weight loss treatment
Coders should verify current guidance in the official publication
